Histiocytosis Cobimetinib (MSK, Nature 2019)

Summary

Histiocytosis Cobimetinib (MSK, Nature 2019) is a study catalogued by cBioPortal DataHub under the cancer-type code hdcn. EvidenceHelix groups it with blood, lymph and bone marrow studies.

Study description

Targeted and whole exome sequencing of 52 histiocytosis tumor/normal pairs.

Text as published in the source's study metadata.

Citation & PubMed

Eli et al. Nature 2019

Linked PubMed records: PMID 30867592

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

histiocytosis_cobi_msk_2019

Short name

HIST (COBI 2019)

Source cancer-type code

hdcn

Reference genome

not given

Source access groups

HYMANHISTCOBI;OMARHISTCOBI;DIAMONDHISTCOBI;PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Eli et al. Nature 2019

• PubMed record 30867592 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Diffuse Large B-Cell Lymphoma (MSK, Haematologica 2024)

  Targeted sequencing of 396 diffuse large B-cell lymphoma samples and their matched normals via MSK-IMPACT.

  Blood, lymph and bone marrowMSK studiesSource code mbnPubMed 1

• Germ Cell Tumors and Shared Leukemias (MSK, J Clin Invest 2020)

  Targeted and WES sequencing of germ cell tumor and shared leukemia samples.

  Blood, lymph and bone marrowMSK studiesSource code testisPubMed 1

• Lymphoma Cell Lines (MSK, Blood 2020)

  Targeted sequencing of 34 lymphoma cell lines using HemePACT_v3

  Blood, lymph and bone marrowMSK studiesSource code lymphPubMed 1

• Mature T and NK Neoplasms (MSK, Blood Adv 2023)

  Targeted sequencing of 132 Mature T and NK Neoplasms and their matched normals via MSK-IMPACT.

  Blood, lymph and bone marrowMSK studiesSource code mtnnPubMed 1

• Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2015)

  Comprehensive profiling of infant MLL-rearranged acute lymphoblastic leukemia (MLL-R ALL)

  Blood, lymph and bone marrowOther published and consortium studiesSource code bllPubMed 1

• Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2016)

  Whole-genome and/or whole-exome sequencing of ERG-altered B-ALL tumor/normal pairs.

  Blood, lymph and bone marrowOther published and consortium studiesSource code bllPubMed 1

• Acute Myeloid Leukemia (OHSU, Cancer Cell 2022)

  Whole-exome and transcriptomic sequencing of 942 acute myeloid leukemia samples (with 500 matched normals) from the Beat AML program.

  Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1

• Acute Myeloid Leukemia (OHSU, Nature 2018)

  Whole-exome sequencing of 672 acute myeloid leukemia samples (with 454 matched normals) from the Beat AML program.

  Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.